News & Resources
The Cancer Immunotherapy Consortium embraces communication and collaboration among its members and among other like-minded associations that strive to bring effective immune-based cancer treatments to more patients.
CIC members contribute to the creation of white papers, response documents, and peer-reviewed publications advancing novel outcomes from workshops that seek practical solutions to today's challenges in cancer immunotherapy development.
We invite you to browse our library of publications, news releases, and e-newsletters.
CRI and MD Becker Partners announced today the release of a joint report titled, "Cancer Immunotherapy: A Roundtable Discussion."
June 29, 2011
The Cancer Immunotherapy Consortium (CIC), a program of the nonprofit Cancer Research Institute, will host its 2011 Scientific Colloquium March 17-19, 2011, at the Gaylord National Hotel and Convention Center in National Harbor, MD.
March 8, 2011
A joint position paper by researchers associated with the Cancer Immunotherapy Consortium of the Cancer Research Institute and the Association for Cancer Immunotherapy, describing the path toward successful generation of a broadly acceptable framework for reporting data from T cell immune assays, was published last week in the journal Cancer Immunology, Immunotherapy.
November 22, 2010
The Cancer Research Institute Cancer Immunotherapy Consortium, the leading global initiative in advancing the emerging field of immuno-oncology, has proposed criteria for improved endpoints for cancer immunotherapy trials, which were published online on September 8 in the Journal of the National Cancer Institute.
September 23, 2010
A significant new immunotherapy, created by CRI Scientific Advisory Council Associate Director James P. Allison, Ph.D, is the first treatment ever proven to extend patient survival in the treatment of melanoma, the deadliest form of skin cancer.
June 7, 2010